Healthstream (HSTM) Invested Capital (2010 - 2026)

Healthstream (HSTM) has 17 years of Invested Capital data on file, last reported at $352.0 million in Q1 2026.

• Quarterly Invested Capital fell 2.98% year-over-year to $352.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $352.0 million (down 2.98% YoY) and the FY2025 annual result came in at $354.0 million, down 1.48% from the prior year.
• Invested Capital fell to $352.0 million in Q1 2026 per HSTM's latest filing, from $354.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $362.8 million in Q1 2025 and bottomed at $322.6 million in Q1 2022.
• The 5-year median for Invested Capital is $344.9 million (2024), against an average of $344.2 million.
• The widest annual swing landed in 2022, when Invested Capital declined 4.23%; it then rose 5.46% in 2024.
• Tracing HSTM's Invested Capital over 5 years: stood at $334.1 million in 2022, then advanced by 2.0% to $340.8 million in 2023, then climbed by 5.46% to $359.4 million in 2024, then declined by 1.48% to $354.0 million in 2025, then fell by 0.57% to $352.0 million in 2026.
• Per Business Quant, the three latest HSTM Invested Capital figures stand at $352.0 million (Q1 2026), $354.0 million (Q4 2025), and $349.2 million (Q3 2025).

Peer Comparison